Medline
MDLN
Source: the SEC Form 13F filings of the managers we follow, latest for mostly Q2 2026. How we use them
Value held
$1.6bn
Combined value at quarter end
Last quarter
1 bought
4 sold or trimmed
Managers holding it, by quarter
0Q4 ’23
0Q1 ’24
0Q2 ’24
0Q3 ’24
0Q4 ’24
0Q1 ’25
0Q2 ’25
0Q3 ’25
4Q4 ’25
5Q1 ’26
4Q2 ’26
1Q3 ’26
Who holds it
| Lone Pine Capital | 5.1%$827m | Added +78% |
| Egerton Capital | 4.7%$461m | Trimmed -19% |
| Durable Capital Partners | 1.0%$104m | Trimmed -64% |
| Viking Global Investors | 0.5%$191m | Trimmed -58% |
Sold out last quarter
- Maverick Capital in Q2 2026
About the company
- Sector
- Health care · Surgical & Medical Instruments & Apparatus
- Incorporated in
- Delaware
- Financial year ends
- 31 December
- SEC filings
- Annual reports and other filings on EDGAR
Revenue and profit
| Year | Revenue | Net income |
|---|---|---|
| 2025 | $28bn | $1.2tn |